ÂÜÀòÂÒÂ×

John Kane has several years of experience in the field of scientific research and development. John is currently working as a Senior Principal Scientist at CreaGen, Inc. since March 2020. Prior to that, they worked as a Senior Development Scientist at GSK from June 2018 to December 2019. From September 2011 to July 2017, they held the position of Senior Scientist at ImmuneXcite, where they were involved in the design, synthesis, and purification of oligosaccharide ligands and antibody-drug conjugates. John also worked as a Scientist I at both SmartCells, Inc. from October 2009 to July 2011, and Mersana Therapeutics from 2006 to 2008. Additionally, they gained valuable experience as a Postdoctoral Researcher at Harvard University from 2003 to 2006.

John Kane received their Doctor of Philosophy (Ph.D.) degree in Organic Chemistry from the University of Notre Dame in the period from 1995 to 2003. John also pursued education at Stony Brook University and Harvard University, although specific details about degrees or fields of study in these institutions are not provided.